KNSA
Kiniksa Pharmaceuticals International, plc
$95.05−0.06 (−0.06%)Close Nov 18, 2026
Loading the growth chart…
Growth of $10,000
May 25, 2018 – Nov 18, 2026, Dividends reinvested
- Final balance
- $48,970
- CAGR
- +20.59%
- Max drawdown
- −83.06%
Trailing returns (%)
KNSA's average annual return was 49.73% over the last 5 years, through Nov 18, 2026. $10,000 in KNSA on Nov 18, 2021 grew to $75,257 by Nov 18, 2026, with dividends reinvested.
Total
- 1M
- +20.94%
- 3M
- +19.57%
- 6M
- +77.20%
- YTD
- +130.42%
- 1Y
- +130.26%
Per year
- 3Y
- +82.22%
- 5Y
- +49.73%
- Since 2018
- +20.59%
Annual returns
2018 from May 25 · 2026 through Nov 18
KNSA returns by year
| Year | Return |
|---|---|
| 2026 through Nov 18 | +130.42% |
| 2025 | +108.54% |
| 2024 | +12.77% |
| 2023 | +17.09% |
| 2022 | +27.27% |
| 2021 | −33.39% |
| 2020 | +59.76% |
| 2019 | −60.63% |
| 2018 from May 25 | +44.72% |
Metrics
Since 2018| Volatility | 63.72% |
|---|---|
| Sharpe ratio | 0.61 |
| Sortino ratio | 0.97 |
| Calmar ratio | 0.25 |
| Longest drawdown | 6.9 years |
Worst drawdowns
Since 2018| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −83.1% | Sep 2018 | Oct 2019 | Aug 2025 | 6.9 years |
| −35.0% | Jun 2018 | Jul 2018 | Aug 2018 | 2 months |
| −21.1% | May 2026 | Jun 2026 | Jun 2026 | 1 month |
| −14.3% | Apr 2026 | Apr 2026 | Apr 2026 | 3 weeks |
| −13.5% | Sep 2018 | Sep 2018 | Sep 2018 | 1 week |